-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Internet medical treatment is a new modern medical treatment method that applies modern computer technology and information technology to the medical process.
Taking medicine and other aspects began to play an increasingly important role
.
Especially after the impact of the epidemic and the further stimulation of consumer demand, it is still being trusted by more and more patients
.
It is worth mentioning that in this context, the Internet medical industry has also ushered in rapid growth and the accelerated listing of Internet medical-related companies
.
Recently, Supai Health Technology Co.
, Ltd.
(hereinafter referred to as "Supai Health") submitted a prospectus to the Hong Kong Stock Exchange and officially announced the impact of the IPO
.
Supai Health is very popular in the capital market, and well-known venture capital such as IDG Capital, Ping An Innovation, Tencent Investment and others have participated in it
.
According to the prospectus, Sipai Health currently has three business lines, including Doctor Research Solution (PRS), Pharmaceutical Benefit Management (PBM) and Supplier and Payer Solution (PPS)
.
Among them, the PBM business is the main source of the company's revenue, accounting for 91.
9% of the company's total revenue in 2020.
The business includes specialty drug pharmacies and patient-centered value-added pharmacist services
.
It is understood that, in addition to Supai Health, this year, including Yidu Technology and Yingtong Technology have come to market news
.
In addition, Internet medical-related companies such as WeDoctor, DingDang Health, Zhiyun Health, Supai Health, Yuanxin Technology, Keya Medical, and Shukun Technology have also submitted prospectuses to the Hong Kong Stock Exchange
.
The industry believes that this is due to China’s accelerating entry into an aging society, the increase in the population of chronic diseases, the continuous expansion of demand for medical and health care, and the continuous promotion of relevant favorable policies.
The market scale of China’s Internet industry continues to grow at a high speed.
Due to continued optimism about the prospects of this field
.
In fact, with the development of Internet technology, the Internet of drug marketing has become a trend, and the normalization of epidemic prevention and control has accelerated the trend of Internet drug circulation
.
Statistics show that in the face of the vast blue ocean of the market, many companies, including Internet giants, are entering the market one after another.
.
In 2020, China registered a total of 61,000 Internet medical-related companies, a year-on-year increase of 23.
3%; and the number of registrations in the first half of 2021 has reached 140,000, a year-on-year increase of 115.
4%
.
However, it should be noted that although the current Internet medical situation is good, it has become a sweet pastry in the eyes of many layout enterprises and even capital, but behind its fiery development, it also requires cold thinking
.
For example, from the current point of view, the Internet medical-related systems, regulations, and professional standards have not been perfected, and the current Internet medical service model has risks such as "reliance on medicines"
.
In addition, issues such as pharmaceutical supervision, information security, and patient privacy protection also need to be resolved urgently
.
In general, in the development of Internet medical care, crises and opportunities coexist.
Only by making ourselves bigger and stronger and having a broader cooperation platform can we create more market opportunities
.
Taking medicine and other aspects began to play an increasingly important role
.
Especially after the impact of the epidemic and the further stimulation of consumer demand, it is still being trusted by more and more patients
.
It is worth mentioning that in this context, the Internet medical industry has also ushered in rapid growth and the accelerated listing of Internet medical-related companies
.
Recently, Supai Health Technology Co.
, Ltd.
(hereinafter referred to as "Supai Health") submitted a prospectus to the Hong Kong Stock Exchange and officially announced the impact of the IPO
.
Supai Health is very popular in the capital market, and well-known venture capital such as IDG Capital, Ping An Innovation, Tencent Investment and others have participated in it
.
According to the prospectus, Sipai Health currently has three business lines, including Doctor Research Solution (PRS), Pharmaceutical Benefit Management (PBM) and Supplier and Payer Solution (PPS)
.
Among them, the PBM business is the main source of the company's revenue, accounting for 91.
9% of the company's total revenue in 2020.
The business includes specialty drug pharmacies and patient-centered value-added pharmacist services
.
It is understood that, in addition to Supai Health, this year, including Yidu Technology and Yingtong Technology have come to market news
.
In addition, Internet medical-related companies such as WeDoctor, DingDang Health, Zhiyun Health, Supai Health, Yuanxin Technology, Keya Medical, and Shukun Technology have also submitted prospectuses to the Hong Kong Stock Exchange
.
The industry believes that this is due to China’s accelerating entry into an aging society, the increase in the population of chronic diseases, the continuous expansion of demand for medical and health care, and the continuous promotion of relevant favorable policies.
The market scale of China’s Internet industry continues to grow at a high speed.
Due to continued optimism about the prospects of this field
.
In fact, with the development of Internet technology, the Internet of drug marketing has become a trend, and the normalization of epidemic prevention and control has accelerated the trend of Internet drug circulation
.
Statistics show that in the face of the vast blue ocean of the market, many companies, including Internet giants, are entering the market one after another.
.
In 2020, China registered a total of 61,000 Internet medical-related companies, a year-on-year increase of 23.
3%; and the number of registrations in the first half of 2021 has reached 140,000, a year-on-year increase of 115.
4%
.
However, it should be noted that although the current Internet medical situation is good, it has become a sweet pastry in the eyes of many layout enterprises and even capital, but behind its fiery development, it also requires cold thinking
.
For example, from the current point of view, the Internet medical-related systems, regulations, and professional standards have not been perfected, and the current Internet medical service model has risks such as "reliance on medicines"
.
In addition, issues such as pharmaceutical supervision, information security, and patient privacy protection also need to be resolved urgently
.
In general, in the development of Internet medical care, crises and opportunities coexist.
Only by making ourselves bigger and stronger and having a broader cooperation platform can we create more market opportunities
.
